SARS-CoV-2 (COVID-19) Clinical Trial 20213042

[LCID Study Number: 20213042]

Compassionate Use of REGN-COV2 for the Treatment of COVID-19

The purpose of this study is to provide Compassionate Use access to REGN-COV2 for adult patients with recently diagnosed mild-to-moderate coronavirus disease (COVID-19) who are at high risk for poor outcomes.

Disease/Condition: SARS-CoV-2 (COVID-19)

Department: Pulmonary and Critical Care

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734

View NCT ID 04617535 on ClinicalTrials.gov
Protocol #: 20213042
Principal Investigator(s): Kenneth M. Wener
Study Coordinator(s): Deborah Gannon
Trial Phase: Sponsor Initiated Study Expanded Access